# MS-ResearchBiomarkerS

> **NCT05204459** · — · RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis, Primary Progressive
- Multiple Sclerosis, Secondary Progressive
- Clinically Isolated Syndrome
- Radiologically Isolated Syndrome
- Neuromyelitis Optica Spectrum Disorders
- Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
- Neurologic Autoimmune Disease
- Neurologic Disorder
- Healthy Aging

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05204459
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-11
- **Primary completion:** 2041-11-11
- **Final completion:** 2041-11-11
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05204459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05204459, "MS-ResearchBiomarkerS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05204459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*